Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Erlotinib can cause nonscarring hair loss and itchy skin.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

A new engineered treatment shows promise in curing heart fibrosis.

Finasteride is a medicine used to treat enlarged prostate and prostate cancer, and it works by changing how testosterone works in the body.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Baricitinib works better than methotrexate for severe alopecia areata.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Nilotinib can cause skin issues like red bumps and hair loss.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.